CarcinoQuant AB is a Swedish AB based in Mölndal, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2018, the company has 0 employees and reported revenue of SEK 0 in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska utveckla och sälja metoder för läkemedelsutveckling och diagnostik inom sjuk- och hälsovårdsbranschen.
In its most recent annual report (2025), CarcinoQuant AB reported revenue of SEK 0. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of SEK 61.9k.
At the end of 2025, equity financed 95.9% of the balance sheet, and current assets covered short-term debt 15 times.
Frequently asked questions
What is the Org number of CarcinoQuant AB?
CarcinoQuant AB is registered with Bolagsverket / SCB under Org 5591684518.
Who is the CEO of CarcinoQuant AB?
Erik Helge Wenzel Nisshagen is the CEO of CarcinoQuant AB, in role since 2026.
Who is the chairman of CarcinoQuant AB?
Nils Lennart Thurfjell chairs the board of CarcinoQuant AB, in role since 2026.
Where is CarcinoQuant AB headquartered?
CarcinoQuant AB's registered address is Förändringens Gata 10.
